Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
COLLINS, M. D., LAWSON, P. A., WILLEMS, A., CORDOBA, J. J., FERNANDEZ-GARAYZABAL, J., GARCIA, P., CAI, J., HIPPE, H., & FARROW, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,669
Cited by
Items 301–400 of 1,009
Gut microbiome and metabolic diseases
Fukuda, S., & Ohno, H. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0399-z · Cited by 170
Bacterial Biofilms in Colorectal Cancer Initiation and Progression
Li, S., Konstantinov, S. R., Smits, R., & Peppelenbosch, M. P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.004 · Cited by 168
Sheng, L., Jena, P. K., Liu, H.-X., Kalanetra, K. M., Gonzalez, F. J., French, S. W., Krishnan, V. V., Mills, D. A., & Wan, Y.-J. Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-01576-9 · Cited by 155
Role of gut microbiota in liver disease
Albhaisi, S. A. M., Bajaj, J. S., & Sanyal, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00118.2019 · Cited by 165
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma
Chai, X., Wang, J., Li, H., Gao, C., Li, S., Wei, C., Huang, J., Tian, Y., Yuan, J., Lu, J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2022.2156255 · Cited by 152
“Both clinical and animal studies have shown that microbial communities can stimulate hepatic inflammatory responses and liver fibrosis and induce IL-6 production, which in turn promotes the development of liver tumors.(13) However, relatively few studies have been conducted on the relationship between microorganisms a…”
BackgroundThe Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes
Sharma, M., Li, Y., Stoll, M. L., & Tollefsbol, T. O. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01329 · Cited by 152
Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
Sangineto, M., Villani, R., Cavallone, F., Romano, A. D., Loizzi, D., & Serviddio, G. (2020) · Cancers · doi:10.3390/cancers12061419 · Cited by 160
Kitada, K., Nakano, D., Ohsaki, H., Hitomi, H., Minamino, T., Yatabe, J., Felder, R. A., Mori, H., Masaki, T., Kobori, H., et al. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.05.010 · Cited by 151
Paternal microbiome perturbations impact offspring fitness
Argaw-Denboba, A., Schmidt, T., Giacomo, M. D., Ranjan, B., Devendran, S., Mastrorilli, E., Lloyd, C. T., Pugliese, D., Paribeni, V., Dabin, J., et al. (2024) · Nature · doi:10.1038/s41586-024-07336-w · Cited by 163
The Gordian Knot of dysbiosis, obesity and NAFLD
Mehal, W. Z. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.146 · Cited by 172
Sipos, A., Ujlaki, G., Mikó, E., Maka, E., Szabó, J., Uray, K., Krasznai, Z. T., & Bai, P. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00295-2 · Cited by 165
Gut microbiota and host metabolism in liver cirrhosis
Usami, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11597 · Cited by 149
The gut microbiota and the metabolic health of the host
Joyce, S. A., & Gahan, C. G. M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000039 · Cited by 147
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors
Dongiovanni, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12945 · Cited by 145
Interactions between dietary flavonoids and the gut microbiome: a comprehensive review
Baky, M. H., Elshahed, M., Wessjohann, L., & Farag, M. A. (2022) · British Journal of Nutrition · doi:10.1017/s0007114521003627 · Cited by 135
The role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144
Self-citationMechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez-Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 141
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
Xiang, J., Zhang, Z., Xie, H., Zhang, C., Bai, Y., Cao, H., Che, Q., Guo, J., & Su, Z. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1949095 · Cited by 149
Microbiota, NASH, HCC and the potential role of probiotics
Brandi, G., De Lorenzo, S., Candela, M., Pantaleo, M. A., Bellentani, S., Tovoli, F., Saccoccio, G., & Biasco, G. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx007 · Cited by 142
Chen, Q.-T., Zhang, Z.-Y., Huang, Q.-L., Chen, H.-Z., Hong, W.-B., Lin, T., Zhao, W.-X., Wang, X.-M., Ju, C.-Y., Wu, L.-Z., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00642-5 · Cited by 130
Hua, F., Li, K., Yu, J.-J., Lv, X.-X., Yan, J., Zhang, X.-W., Sun, W., Lin, H., Shang, S., Wang, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8951 · Cited by 140
Clinical Trial Landscape in NASH
Harrison, S. A., Loomba, R., Dubourg, J., Ratziu, V., & Noureddin, M. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.03.041 · Cited by 137
Senescent cells communicate via intercellular protein transfer
Biran, A., Perelmutter, M., Gal, H., Burton, D. G. A., Ovadya, Y., Vadai, E., Geiger, T., & Krizhanovsky, V. (2015) · Genes & Development · doi:10.1101/gad.259341.115 · Cited by 139
“However, if senescent cells persist in tissues, the secretory phenotype can contribute to local inflammation and attenuate tissue repair, features associated with aging (Freund et al. 2010; Yoshimoto et al. 2013; Ovadya and Krizhanovsky 2014).”
Microbial markers in colorectal cancer detection and/or prognosis
Villéger, R., Lopès, A., Véziant, J., Gagnière, J., Barnich, N., Billard, E., Boucher, D., & Bonnet, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2327 · Cited by 158
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Tanaka, N., Kimura, T., Fujimori, N., Nagaya, T., Komatsu, M., & Tanaka, E. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i2.163 · Cited by 138
Liu, J., Geng, W., Sun, H., Liu, C., Huang, F., Cao, J., Xia, L., Zhao, H., Zhai, J., Li, Q., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-325189 · Cited by 154
Chini, C., Hogan, K. A., Warner, G. M., Tarragó, M. G., Peclat, T. R., Tchkonia, T., Kirkland, J. L., & Chini, E. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.199 · Cited by 138
Exploring and Understanding the Biochemical Diversity of the Human Microbiota
Koppel, N., & Balskus, E. P. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.12.008 · Cited by 154
Ridlon, J. M., Devendran, S., Alves, J. M., Doden, H., Wolf, P. G., Pereira, G. V., Ly, L., Volland, A., Takei, H., Nittono, H., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1618173 · Cited by 136
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
Qiu, Q., Lin, Y., Ma, Y., Li, X., Liang, J. B., Chen, Z., Liu, K., Huang, Y., Luo, H., Huang, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612202 · Cited by 152
Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention
Lange, N. F., Radu, P., & Dufour, J.-F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.025 · Cited by 133
Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota
Kang, Y., Li, Y., Du, Y., Guo, L., Chen, M., Huang, X., Fang, Y., Hong, J., & Kong, X. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0187-x · Cited by 148
In vitro and in vivo characterization of Clostridium scindens bile acid transformations
Marion, S., Studer, N., Desharnais, L., Menin, L., Escrig, S., Meibom, A., Hapfelmeier, S., & Bernier-Latmani, R. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1549420 · Cited by 133
The microbiome and cancer for clinicians
Picardo, S. L., Coburn, B. A., & Hansen, A. R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.06.004 · Cited by 150
The microbiome and its potential as a cancer preventive intervention
Bultman, S. J. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.001 · Cited by 134
Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
Boursier, J., & Diehl, A. M. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004559 · Cited by 132
Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis
Schneditz, G., Rentner, J., Roier, S., Pletz, J., Herzog, K. A. T., Bücker, R., Troeger, H., Schild, S., Weber, H., Breinbauer, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403274111 · Cited by 135
Caussy, C., Hsu, C., Singh, S., Bassirian, S., Kolar, J., Faulkner, C., Sinha, N., Bettencourt, R., Gara, N., Valasek, M. A., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15035 · Cited by 129
The microbiome and hepatobiliary-pancreatic cancers
Mima, K., Nakagawa, S., Sawayama, H., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., Baba, Y., Yamashita, Y., Yoshida, N., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.001 · Cited by 144
Role of Gut Microbiota in Hepatocarcinogenesis
Gupta, H., Youn, G. S., Shin, M. J., & Suk, K. T. (2019) · Microorganisms · doi:10.3390/microorganisms7050121 · Cited by 140
Wu, M., Brockmeyer, T., Hartmann, M., Skunde, M., Herzog, W., & Friederich, H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.017 · Cited by 148
Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization
Aymeric, L., Donnadieu, F., Mulet, C., du Merle, L., Nigro, G., Saffarian, A., Berard, M., Poyart, C., Robine, S., Regnault, B., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715112115 · Cited by 153
The Microbiome as a Component of the Tumor Microenvironment
Kovàcs, T., Mikó, E., Ujlaki, G., Sári, Z., & Bai, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_10 · Cited by 140
Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
Salam, R., Saliou, A., Bielle, F., Bertrand, M., Antoniewski, C., Carpentier, C., Alentorn, A., Capelle, L., Sanson, M., Huillard, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36124-9 · Cited by 132
Sheng, L., Jena, P. K., Hu, Y., Liu, H., Nagar, N., Kalanetra, K. M., French, S. W., French, S. W., Mills, D. A., & Wan, Y. Y. (2017) · The Journal of Pathology · doi:10.1002/path.4983 · Cited by 133
Gonzalez-Meljem, J. M., Haston, S., Carreno, G., Apps, J. R., Pozzi, S., Stache, C., Kaushal, G., Virasami, A., Panousopoulos, L., Mousavy-Gharavy, S. N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01992-5 · Cited by 130
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Hu, M., Wang, Y., Xu, L., An, S., Tang, Y., Zhou, X., Li, J., Liu, R., & Huang, L. (2019) · Nature Communications · doi:10.1038/s41467-019-10893-8 · Cited by 133
Pushpass, R.-A. G., Alzoufairi, S., Jackson, K. G., & Lovegrove, J. A. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000081 · Cited by 143
Role of hypoxia in cellular senescence
Gao, H., Nepovimová, E., Heger, Z., Valko, M., Wu, Q., Kuča, K., & Adam, V. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106841 · Cited by 146
Microbial Metabolites and Gut Immunology
Takeuchi, T., Nakanishi, Y., & Ohno, H. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090222-102035 · Cited by 149
Yamada, S., Takashina, Y., Watanabe, M., Nagamine, R., Saito, Y., Kamada, N., & Saito, H. (2018) · Oncotarget · doi:10.18632/oncotarget.24066 · Cited by 129
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Rahman, M. M., Islam, M. R., Shohag, S., Ahasan, M. T., Sarkar, N., Khan, H., Hasan, A. M., Cavalu, S. D., & Rauf, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112898 · Cited by 142
Cross-talk between bile acids and intestinal microbiota in host metabolism and health
Nie, Y.-F., Hu, J., & Yan, X.-H. (2015) · Journal of Zhejiang University-SCIENCE B · doi:10.1631/jzus.b1400327 · Cited by 126
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
Sydor, S., Best, J., Messerschmidt, I., Manka, P., Vilchez-Vargas, R., Brodesser, S., Lucas, C., Wegehaupt, A., Wenning, C., Aßmuth, S., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000131 · Cited by 127
“Furthermore, levels of hydrophobic BA such as TCDCA and TLCA are altered in high fat diet mouse models and may contribute to carcinogenesis inNASHby promoting cell proliferation and inflammation (38).”
BackgroundInfluentialChng, K. R., Chan, S. H., Ng, A. H. Q., Li, C., Jusakul, A., Bertrand, D., Wilm, A., Choo, S. P., Tan, D. M. Y., Lim, K. H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.034 · Cited by 127
Mukherjee, S., Joardar, N., Sengupta, S., & Sinha Babu, S. P. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.07.010 · Cited by 124
The role of key gut microbial metabolites in the development and treatment of cancer
Jaye, K., Li, C. G., Chang, D., & Bhuyan, D. J. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2038865 · Cited by 122
Metabolic interplays between the tumour and the host shape the tumour macroenvironment
Altea‐Manzano, P., Decker-Farrell, A. R., Janowitz, T., & Erez, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00786-4 · Cited by 150
Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
Takaki, A., Kawai, D., & Yamamoto, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057352 · Cited by 126
Wasimuddin, Menke, S., Melzheimer, J., Thalwitzer, S., Heinrich, S. K., Wachter, B., & Sommer, S. (2017) · Molecular Ecology · doi:10.1111/mec.14278 · Cited by 148
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota
Ohtani, N., & Hara, E. (2021) · Cancer Science · doi:10.1111/cas.15142 · Cited by 138
Self-citationSchnabl, B., Damman, C. J., & Carr, R. M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186423 · Cited by 142
Hepatocellular carcinoma and lifestyles
Saran, U., Humar, B., Kolly, P., & Dufour, J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.028 · Cited by 134
Ren, Z., Chen, X., Hong, L., Zhao, X., Cui, G., Li, A., Liu, Y., Zhou, L., Sun, R., Shen, S., et al. (2019) · Small · doi:10.1002/smll.201905233 · Cited by 131
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
Machado, M., & Cortez-Pinto, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040481 · Cited by 123
Gut microbiome and anticancer immune response: really hot Sh*t!
Viaud, S., Daillère, R., Boneca, I. G., Lepage, P., Langella, P., Chamaillard, M., Pittet, M. J., Ghiringhelli, F., Trinchieri, G., Goldszmid, R., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.56 · Cited by 123
Mannan-oligosaccharide modulates the obesity and gut microbiota in high-fat diet-fed mice
Wang, H., Zhang, X., Wang, S., Li, H., Lu, Z., Shi, J., & Xu, Z. (2018) · Food & Function · doi:10.1039/c8fo00209f · Cited by 120
Xiang, D., Zou, J., Zhu, X., Chen, X., Luo, J., Kong, L., & Zhang, H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153294 · Cited by 137
Nutrition and Genetics in NAFLD: The Perfect Binomium
Meroni, M., Longo, M., Rustichelli, A., & Dongiovanni, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082986 · Cited by 140
Janssen, A. W. F., Houben, T., Katiraei, S., Dijk, W., Boutens, L., van der Bolt, N., Wang, Z., Brown, J. M., Hazen, S. L., Mandard, S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075713 · Cited by 122
The path toward using microbial metabolites as therapies
Descamps, H. C., Herrmann, B., Wiredu, D., & Thaiss, C. A. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.063 · Cited by 123
The microbiota and the gut–liver axis in primary sclerosing cholangitis
Hov, J. R., & Karlsen, T. H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00690-y · Cited by 141
Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy
Wan, M. L. Y., & El-Nezami, H. (2018) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.12.07 · Cited by 120
Doden, H., Sallam, L. A., Devendran, S., Ly, L., Doden, G., Daniel, S. L., Alves, J. M. P., & Ridlon, J. M. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.00235-18 · Cited by 118
Microbiota in cancer development and treatment
Raza, M. H., Gul, K., Arshad, A., Riaz, N., Waheed, U., Rauf, A., Aldakheel, F. M., Alduraywish, S. A., Rehman, M. U., Abdullah, M., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2816-0 · Cited by 129
Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer
Kovács, P., Csonka, T., Kovàcs, T., Sári, Z., Ujlaki, G., Sipos, A. A., Karányi, Z., Szeőcs, D., Hegedűs, C., Uray, K., et al. (2019) · Cancers · doi:10.3390/cancers11091255 · Cited by 126
Stressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119
Nishitsuji, K., Xiao, J., Nagatomo, R., Umemoto, H., Morimoto, Y., Akatsu, H., Inoue, K., & Tsuneyama, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-16189-5 · Cited by 118
Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction
Horáčková, Š., Plocková, M., & Demnerová, K. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.005 · Cited by 135
Paneth cell α-defensins and enteric microbiota in health and disease
NAKAMURA, K., SAKURAGI, N., TAKAKUWA, A., & AYABE, T. (2016) · Bioscience of Microbiota, Food and Health · doi:10.12938/bmfh.2015-019 · Cited by 114
Tao, J., Li, S., Gan, R.-Y., Zhao, C.-N., Meng, X., & Li, H.-B. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1555789 · Cited by 119
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
Tsuei, J., Chau, T., Mills, D., & Wan, Y.-J. Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538743 · Cited by 116
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00913-4 · Cited by 117
“111).”
Xenobiotics: Interaction with the Intestinal Microflora
Lu, K., Mahbub, R., & Fox, J. G. (2015) · ILAR Journal · doi:10.1093/ilar/ilv018 · Cited by 117
Armstrong, H., Bording-Jorgensen, M., Dijk, S., & Wine, E. (2018) · Cancers · doi:10.3390/cancers10030083 · Cited by 118
Meng, X., Li, S., Li, Y., Gan, R.-Y., & Li, H.-B. (2018) · Nutrients · doi:10.3390/nu10101457 · Cited by 115
An overview of cancer health disparities: new approaches and insights and why they matter
Minas, T. Z., Kiely, M., Ajao, A., & Ambs, S. (2021) · Carcinogenesis · doi:10.1093/carcin/bgaa121 · Cited by 115
Gut Microbiota in Intestinal and Liver Disease
Jones, R. M., & Neish, A. S. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-030320-095722 · Cited by 123
Diet Effects in Gut Microbiome and Obesity
Chen, J., He, X., & Huang, J. (2014) · Journal of Food Science · doi:10.1111/1750-3841.12397 · Cited by 114
Of Flies, Mice, and Men: Evolutionarily Conserved Tissue Damage Responses and Aging
Neves, J., Demaria, M., Campisi, J., & Jasper, H. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.11.028 · Cited by 118
Roles of hepatic stellate cells in liver inflammation: a new perspective
Fujita, T., & Narumiya, S. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0005-6 · Cited by 113
Sheflin, A. M., Borresen, E. C., Kirkwood, J. S., Boot, C. M., Whitney, A. K., Lu, S., Brown, R. J., Broeckling, C. D., Ryan, E. P., & Weir, T. L. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500905 · Cited by 113
Emerging Concepts Linking Obesity with the Hallmarks of Cancer
Donohoe, C. L., Lysaght, J., O'Sullivan, J. N., & Reynolds, J. V. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.08.004 · Cited by 132
Litmanovich, A., Khazim, K., & Cohen, I. (2018) · Oncology and Therapy · doi:10.1007/s40487-018-0089-z · Cited by 116
Dowman, J. K., Hopkins, L. J., Reynolds, G. M., Nikolaou, N., Armstrong, M. J., Shaw, J. C., Houlihan, D. D., Lalor, P. F., Tomlinson, J. W., Hübscher, S. G., et al. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.01.034 · Cited by 116
Bile Acids and Cancer: Direct and Environmental-Dependent Effects
Ciaula, A. D., Wang, D. Q. ‐., Molina‐Molina, E., Baccetto, R., Calamita, G., Palmieri, V. O., & Portincasa, P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5501 · Cited by 127
Kawamura, S., Matsushita, Y., Kurosaki, S., Tange, M., Fujiwara, N., Hayata, Y., Hayakawa, Y., Suzuki, N., Hata, M., Tsuboi, M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151895 · Cited by 115
Dumas, M.-E., Rothwell, A. R., Hoyles, L., Aranias, T., Chilloux, J., Calderari, S., Noll, E. M., Péan, N., Boulangé, C. L., Blancher, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.039 · Cited by 114
“, prodromal) markers of disease onset and progression and to assess their impact on disease (Hsiao et al., 2013; Venkatesh et al., 2014; Yoshimoto et al., 2013).”
BackgroundLunyak, V. V., Amaro-Ortiz, A., & Gaur, M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00220 · Cited by 114
Cellular senescence: a promising strategy for cancer therapy
Lee, S., & Lee, J.-S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.294 · Cited by 115
Metadata
- Authors
- Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., Honda, K., Ishikawa, Y., Hara, E., & Ohtani, N.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokyo University of Science (JP)
- Japan Science and Technology Agency (JP)
- Tokushima University (JP)
- The University of Tokyo (JP)
- Azabu University (JP)
- Corresponding author
- Hara, Eiji
- ORCID
- Venue
- Nature
- Published
- 2013-06-26
- Volume
- 499
- Issue
- 7456
- Pages
- 97-101
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2132406938
- Cited by
- 2,219
- References
- 40
- Citations by year
- 2026: 131 · 2025: 164 · 2024: 175 · 2023: 196 · 2022: 208 · 2021: 224 · 2020: 198 · 2019: 175 · 2018: 172 · 2017: 142 · 2016: 130 · 2015: 125 · 2014: 125 · 2013: 47
- FWCI
- 63.80
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-29)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science (23300343, 221S0001, 24650625, 23300352, 25293080)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obesity, hepatocellular carcinoma, senescence-associated secretory phenotype, deoxycholic acid, gut microbiota, hepatic stellate cells, high-fat diet, bile acid metabolism, DNA damage, carcinogenesis, antibiotic intervention, chemical carcinogens, inflammation, obesity-related cancer, therapeutic target, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Bile Acids and Salts, Cells, Cultured, Deoxycholic Acid, Dietary Fats, Disease Models, Animal, DNA Damage, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Phenotype, Risk Factors, Cytokines, Cellular Senescence, Gastrointestinal Tract, Mice, Interleukin-1beta, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.